397328-49-3

Basic information

• Product Name: 3-(4-CHLORO-2-AMINOPHENYL)ACRYLIC ACID ETHYL ESTER
• Synonyms: 3-(4-CHLORO-2-AMINOPHENYL)ACRYLIC ACID ETHYL ESTER;Ethyl 3-(2-aMino-4-chlorophenyl)acrylate
• CAS NO: 397328-49-3
• Molecular Formula: C11H12ClNO2
• Molecular Weight: 225.674
• Mol File: 397328-49-3.mol

Chemical Properties

• Boiling Point: 371.3°C at 760 mmHg
• Flash Point: 178.4°C
• Appearance: /
• Density: 1.245g/cm³
• Vapor Pressure: 1.04E-05mmHg at 25°C
• Refractive Index: 1.604
• Storage Temp.: 2-8°C
• PKA: 0.66±0.10(Predicted)
• CAS DataBase Reference: 3-(4-CHLORO-2-AMINOPHENYL)ACRYLIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-CHLORO-2-AMINOPHENYL)ACRYLIC ACID ETHYL ESTER(397328-49-3)
• EPA Substance Registry System: 3-(4-CHLORO-2-AMINOPHENYL)ACRYLIC ACID ETHYL ESTER(397328-49-3)

Safety Data

• Hazardous Substances Data: 397328-49-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
3-(4-Chloro-2-aminophenyl)acrylic acid ethyl ester is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the formation of diverse drug structures. Its presence in the molecular structure can influence the pharmacological properties of the final product, making it a valuable component in drug development.
Used in Organic Compound Synthesis:
In the field of organic chemistry, 3-(4-Chloro-2-aminophenyl)acrylic acid ethyl ester is used as a building block for the synthesis of various organic compounds. Its reactivity and functional groups allow for a wide range of chemical reactions, facilitating the creation of complex organic molecules for various applications.
It is important to handle and store 3-(4-Chloro-2-aminophenyl)acrylic acid ethyl ester with care, as it is a potentially hazardous chemical that can cause harm if not handled properly.

InChI:InChI=1/C11H12ClNO2/c1-2-15-11(14)6-4-8-3-5-9(12)7-10(8)13/h3-7H,2,13H2,1H3/b6-4+

Upstream product

• 231294-99-8 ethyl 3-(4-chloro-2-nitrophenyl)acrylate 
• 41513-04-6 2-chloro-5-bromonitrobenzene 
• 140-88-5 ethyl acrylate 
• 144-55-8 sodium hydrogencarbonate 
• 6828-35-9 5-chloro-2-iodoaniline 

Relevant articles and documents

Recycled Pd/C-Catalyzed Heck Reaction of 2-Iodoanilines under Ligand-Free Conditions

Recyclable Pd/C-catalyzed Heck reaction of 2-iodoanilines with acrylate has been developed. The reaction occurred readily in 1,4-dioxane using Pd/C (10 wt%) as catalyst under ligand-free conditions, and the cross-coupling products were obtained with medium to high yield. Gram-scale reactions and recycling of the catalyst were also demonstrated.

Palladium catalyzed Heck reaction of 2-iodoanilines under ligand-free conditions in air

Palladium catalyzed Heck reaction of 2-iodoanilines and acrylate has been developed. The palladium catalyzed Heck reaction of 2-iodoanilines can readily occur in CH3CN using Pd(OAc)2 (5.0 mol%) as catalyst, NEt3 as base un

Continuous Consecutive Reactions with Inter-Reaction Solvent Exchange by Membrane Separation

Pharmaceutical production typically involves multiple reaction steps with separations between successive reactions. Two processes which complicate the transition from batch to continuous operation in multistep synthesis are solvent exchange (especially high-boiling- to low-boiling-point solvent), and catalyst separation. Demonstrated here is membrane separation as an enabling platform for undertaking these processes during continuous operation. Two consecutive reactions are performed in different solvents, with catalyst separation and inter-reaction solvent exchange achieved by continuous flow membrane units. A Heck coupling reaction is performed in N,N-dimethylformamide (DMF) in a continuous membrane reactor which retains the catalyst. The Heck reaction product undergoes solvent exchange in a counter-current membrane system where DMF is continuously replaced by ethanol. After exchange the product dissolved in ethanol passes through a column packed with an iron catalyst, and undergoes reduction (>99 % yield).

ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS

The present invention relates to inhibitors of histone deacetylases, in particular HDAC8, that are useful for the treatment of cancer and other diseases and disorders, as well as the synthesis and applications of said inhibitors.

Efficient synthesis of [6-chloro-2-(4-chlorobenzoyl)-1H-indol-3-yl]acetic acid, a novel COX-2 inhibitor

The synthesis of 6-chloro-2-(4-chlorobenzoyl)-1H-indol-3-ylacetic acid (1), a selective cyclooxygenase 2 (COX-2) inhibitor, is described. The synthesis relied on a novel indole formation that involved an alkylation/1,4-addition/elimination/isomerization cascade. It was demonstrated that the entire sequence from sulfonamide 13 and bromoketone 14 to the desired indole (1) could be executed in a single pot.

2,3-substituted indole compounds as anti-inflammatory and analgesic agents

This invention provides a compound of the following formula: or the pharmaceutically acceptable salts thereof wherein Z is OH, C1-6 alkoxy, —NR2R3 or heterocycle; Q is selected from the following: (a) an optionally substituted phenyl, (b) an optionally substituted 6-membered monocyclic aromatic group containing one, two, three or four nitrogen atom(s), (c) an optionally substituted 5-membered monocyclic aromatic group containing one heteroatom selected from O, S and N and optionally containing one, two or three nitrogen atom(s) in addition to said heteroatom, (d) an optionally substituted C3-7 cycloalkyl and (e) an optionally substituted benzo-fuzed heterocycle; R1 is hydrogen, C1-4 alkyl or halo; R2 and R3 are independently hydrogen, OH, C1-4 alkoxy, C1-4 alkyl or C1-4 alkyl substituted with halo, OH, C1-4 alkoxy or CN; X is independently selected from H, halo, C1-4 alkyl, halo-substituted C1-4 alkyl, OH, C1-4 alkoxy, halo-substituted C1-4 alkoxy, C1-4 alkylthio, NO2, NH2, di-(C1-4 alkyl)amino and CN; and n is 0, 1, 2, 3 and 4.This invention also provides a pharmaceutical composition useful for the treatment of a medical condition in which prostaglandins are implicated as pathogens.